The Europe biostimulants market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.9 Billion by 2032, exhibiting a growth rate (CAGR) of 9.3% during 2024-2032.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 1.7 Billion |
Market Forecast in 2032
|
US$ 3.9 Billion |
Market Growth Rate (2024-2032) | 9.3% |
Biostimulants are agricultural chemicals made using microorganisms, trace elements, plant hormones, enzymes, and seaweed extracts. They assist in reducing dependency on fertilizers and enhancing crop productivity. As they comprise naturally occurring growth hormones, they support sustainable agricultural practices that improve soil fertility and maintain the ecosystem of the soil, flora, and fauna. Moreover, due to their performance efficiency, biostimulants are replacing agrochemicals across Europe.
Europe represents one of the biggest markets for biostimulants, which can be accredited to increasing concerns about soil health, sustainability and environmental safety. As a result, biostimulants are widely used with organic manure to improve soil fertility and plant health. Additionally, the European Union (EU) has established stringent regulations to support organic farming and promote ecological safety. This, in confluence with rising awareness among individuals about the impact of chemically synthesized pesticides and fertilizers on human health, is strengthening the growth of the market in the region. Moreover, as biostimulants are non-toxic and they do not contaminate the soil, their widespread adoption is growing in different parts of Europe. However, the surging cases of coronavirus disease (COVID-19) have negatively impacted the overall market growth on account of the imposition of lockdown by governing authorities and a temporary halt in the operations of manufacturing units. It is expected to recover due to innovations in the field of agricultural sciences and rising research and development (R&D) activities across the region.
IMARC Group provides an analysis of the key trends in each segment of the Europe biostimulants market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on product type, crop type, form, origin, distribution channel, application and end-user.
Breakup by Product Type:
Breakup by Crop Type:
Breakup by Form:
Breakup by Origin:
Breakup by Distribution Channel:
Breakup by Application:
Breakup by End-User:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Billion |
Segment Coverage | Product Type, Crop Type, Form, Origin, Distribution Channel, Application, End-User, Country |
Countries Covered | Germany, France, United Kingdom, Italy, Spain |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |